.png)
.png)
IN-PART Global Challenge - Virtual Series: Partnering opportunities with Immunitas Therapeutics
What are industry’s top priorities?
Surfacing the next generation of immuno-oncology research and assets for solid tumour cancers
In the first of this three-part event, we’ll be speaking with external innovation and R&D teams at Immunitas Therapeutics to hear about the immuno-oncology research and assets they’re looking for.
Format: Presentation followed by live Q&A (~40 minutes). Opportunity to connect directly with the panelists. Free to attend.
Surfacing the next generation of immuno-oncology research and assets for solid tumour cancers
In the first of this three-part event, we’ll be speaking with external innovation and R&D teams at Immunitas Therapeutics to hear about the immuno-oncology research and assets they’re looking for.
Format: Presentation followed by live Q&A (~40 minutes). Opportunity to connect directly with the panelists. Free to attend.